Medpage Today on MSN
New Hepatitis B Guidelines; DILI in Men vs Women; GERD and Rapid Metabolization
An economic evaluation found that screening followed by intensive lifestyle intervention plus either semaglutide (Ozempic, ...
MedPage Today on MSN
Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study
PHOENIX -- Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, ...
This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...
GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...
Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...
17don MSNOpinion
Ozempic for All
Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.
Hackensack Meridian Health's endocrinology team is working to bring advanced diabetes care closer to home for the state's 693 ...
The Independent on MSN
Ozempic and Wegovy might help slow how fast you get drunk, new research finds
Approximately 178,000 people die from excessive drinking each year. But researchers say popular weight loss drugs could help ...
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...
This is going to have unforeseen consequences for Americans if this trend continues. The post American Obesity Rates Are Now ...
Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes. The approval makes ...
Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results